Screening policies for cytomegalovirus in pregnancy in the era of antivirals
Monitoring (maternal blood tests, serum valaciclovir concentrations, fetal ultrasounds) was uneventful. [...]off-licence antiviral treatment with valganciclovir (900 mg twice daily) was initiated after discussions with the multidisciplinary team, for a total of 6 weeks in the acute phase of presumed...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2022-08, Vol.400 (10351), p.489-490 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 490 |
|---|---|
| container_issue | 10351 |
| container_start_page | 489 |
| container_title | The Lancet (British edition) |
| container_volume | 400 |
| creator | Roberts, Sophie Louise Kendall, Giles S Edwards, Sarah Pandya, Pranav Peebles, Donald Nastouli, Eleni |
| description | Monitoring (maternal blood tests, serum valaciclovir concentrations, fetal ultrasounds) was uneventful. [...]off-licence antiviral treatment with valganciclovir (900 mg twice daily) was initiated after discussions with the multidisciplinary team, for a total of 6 weeks in the acute phase of presumed fetal myocarditis. There is an urgent public health need to create a unified and equitable approach to screening, surveillance, and treatment, especially as some pregnant women are receiving inconsistent care across countries, following different policies. |
| doi_str_mv | 10.1016/S0140-6736(22)01299-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2702485566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673622012995</els_id><sourcerecordid>2701012810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-4f8a36715d774b7b389df3269e423613d5daf50319671945855aafa4905f65a43</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMoWKs_QVjwUg-rSTYf3ZNI8QsKHqrgLaTZSU3ZJjXZLfTfm7biwYunYeB5X2YehC4JviGYiNsZJgyXQlZiROk1JrSuS36EBoRJVnImP47R4Bc5RWcpLTHGTGA-QNOZiQDe-UWxDq0zDlJhQyzMtgsrWOg2bFzsU-F8sY6w8Nqb7W7pPqGAqItgC-07lyHdpnN0YvOAi585RO-PD2-T53L6-vQyuZ-WhhHZlcyOdSUk4Y2UbC7n1bhubEVFDYxWglQNb7TluCJ1hmrGx5xrbTWrMbeCa1YN0ejQu47hq4fUqZVLBtpWewh9UlRiynJKiIxe_UGXoY8-X7ejsj46JjhT_ECZGFKKYNU6upWOW0Ww2jlWe8dqJ1BRqvaOFc-5u0MO8rcbB1GlbNAbaFwE06kmuH8avgGX4YHm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2701012810</pqid></control><display><type>article</type><title>Screening policies for cytomegalovirus in pregnancy in the era of antivirals</title><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Roberts, Sophie Louise ; Kendall, Giles S ; Edwards, Sarah ; Pandya, Pranav ; Peebles, Donald ; Nastouli, Eleni</creator><creatorcontrib>Roberts, Sophie Louise ; Kendall, Giles S ; Edwards, Sarah ; Pandya, Pranav ; Peebles, Donald ; Nastouli, Eleni ; UCL cCMV MDT</creatorcontrib><description>Monitoring (maternal blood tests, serum valaciclovir concentrations, fetal ultrasounds) was uneventful. [...]off-licence antiviral treatment with valganciclovir (900 mg twice daily) was initiated after discussions with the multidisciplinary team, for a total of 6 weeks in the acute phase of presumed fetal myocarditis. There is an urgent public health need to create a unified and equitable approach to screening, surveillance, and treatment, especially as some pregnant women are receiving inconsistent care across countries, following different policies.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(22)01299-5</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Amniocentesis ; Antiviral agents ; Antiviral drugs ; Blood tests ; Congenital diseases ; Cytomegalovirus ; Heart diseases ; Infections ; Medical screening ; Multidisciplinary teams ; Myocarditis ; Policies ; Pregnancy ; Public health ; Serology ; Vaccines ; Womens health</subject><ispartof>The Lancet (British edition), 2022-08, Vol.400 (10351), p.489-490</ispartof><rights>2022 Elsevier Ltd</rights><rights>2022. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-4f8a36715d774b7b389df3269e423613d5daf50319671945855aafa4905f65a43</citedby><cites>FETCH-LOGICAL-c417t-4f8a36715d774b7b389df3269e423613d5daf50319671945855aafa4905f65a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2701012810?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids></links><search><creatorcontrib>Roberts, Sophie Louise</creatorcontrib><creatorcontrib>Kendall, Giles S</creatorcontrib><creatorcontrib>Edwards, Sarah</creatorcontrib><creatorcontrib>Pandya, Pranav</creatorcontrib><creatorcontrib>Peebles, Donald</creatorcontrib><creatorcontrib>Nastouli, Eleni</creatorcontrib><creatorcontrib>UCL cCMV MDT</creatorcontrib><title>Screening policies for cytomegalovirus in pregnancy in the era of antivirals</title><title>The Lancet (British edition)</title><description>Monitoring (maternal blood tests, serum valaciclovir concentrations, fetal ultrasounds) was uneventful. [...]off-licence antiviral treatment with valganciclovir (900 mg twice daily) was initiated after discussions with the multidisciplinary team, for a total of 6 weeks in the acute phase of presumed fetal myocarditis. There is an urgent public health need to create a unified and equitable approach to screening, surveillance, and treatment, especially as some pregnant women are receiving inconsistent care across countries, following different policies.</description><subject>Amniocentesis</subject><subject>Antiviral agents</subject><subject>Antiviral drugs</subject><subject>Blood tests</subject><subject>Congenital diseases</subject><subject>Cytomegalovirus</subject><subject>Heart diseases</subject><subject>Infections</subject><subject>Medical screening</subject><subject>Multidisciplinary teams</subject><subject>Myocarditis</subject><subject>Policies</subject><subject>Pregnancy</subject><subject>Public health</subject><subject>Serology</subject><subject>Vaccines</subject><subject>Womens health</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1LAzEQhoMoWKs_QVjwUg-rSTYf3ZNI8QsKHqrgLaTZSU3ZJjXZLfTfm7biwYunYeB5X2YehC4JviGYiNsZJgyXQlZiROk1JrSuS36EBoRJVnImP47R4Bc5RWcpLTHGTGA-QNOZiQDe-UWxDq0zDlJhQyzMtgsrWOg2bFzsU-F8sY6w8Nqb7W7pPqGAqItgC-07lyHdpnN0YvOAi585RO-PD2-T53L6-vQyuZ-WhhHZlcyOdSUk4Y2UbC7n1bhubEVFDYxWglQNb7TluCJ1hmrGx5xrbTWrMbeCa1YN0ejQu47hq4fUqZVLBtpWewh9UlRiynJKiIxe_UGXoY8-X7ejsj46JjhT_ECZGFKKYNU6upWOW0Ww2jlWe8dqJ1BRqvaOFc-5u0MO8rcbB1GlbNAbaFwE06kmuH8avgGX4YHm</recordid><startdate>20220813</startdate><enddate>20220813</enddate><creator>Roberts, Sophie Louise</creator><creator>Kendall, Giles S</creator><creator>Edwards, Sarah</creator><creator>Pandya, Pranav</creator><creator>Peebles, Donald</creator><creator>Nastouli, Eleni</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20220813</creationdate><title>Screening policies for cytomegalovirus in pregnancy in the era of antivirals</title><author>Roberts, Sophie Louise ; Kendall, Giles S ; Edwards, Sarah ; Pandya, Pranav ; Peebles, Donald ; Nastouli, Eleni</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-4f8a36715d774b7b389df3269e423613d5daf50319671945855aafa4905f65a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amniocentesis</topic><topic>Antiviral agents</topic><topic>Antiviral drugs</topic><topic>Blood tests</topic><topic>Congenital diseases</topic><topic>Cytomegalovirus</topic><topic>Heart diseases</topic><topic>Infections</topic><topic>Medical screening</topic><topic>Multidisciplinary teams</topic><topic>Myocarditis</topic><topic>Policies</topic><topic>Pregnancy</topic><topic>Public health</topic><topic>Serology</topic><topic>Vaccines</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roberts, Sophie Louise</creatorcontrib><creatorcontrib>Kendall, Giles S</creatorcontrib><creatorcontrib>Edwards, Sarah</creatorcontrib><creatorcontrib>Pandya, Pranav</creatorcontrib><creatorcontrib>Peebles, Donald</creatorcontrib><creatorcontrib>Nastouli, Eleni</creatorcontrib><creatorcontrib>UCL cCMV MDT</creatorcontrib><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roberts, Sophie Louise</au><au>Kendall, Giles S</au><au>Edwards, Sarah</au><au>Pandya, Pranav</au><au>Peebles, Donald</au><au>Nastouli, Eleni</au><aucorp>UCL cCMV MDT</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening policies for cytomegalovirus in pregnancy in the era of antivirals</atitle><jtitle>The Lancet (British edition)</jtitle><date>2022-08-13</date><risdate>2022</risdate><volume>400</volume><issue>10351</issue><spage>489</spage><epage>490</epage><pages>489-490</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>Monitoring (maternal blood tests, serum valaciclovir concentrations, fetal ultrasounds) was uneventful. [...]off-licence antiviral treatment with valganciclovir (900 mg twice daily) was initiated after discussions with the multidisciplinary team, for a total of 6 weeks in the acute phase of presumed fetal myocarditis. There is an urgent public health need to create a unified and equitable approach to screening, surveillance, and treatment, especially as some pregnant women are receiving inconsistent care across countries, following different policies.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/S0140-6736(22)01299-5</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2022-08, Vol.400 (10351), p.489-490 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2702485566 |
| source | Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Amniocentesis Antiviral agents Antiviral drugs Blood tests Congenital diseases Cytomegalovirus Heart diseases Infections Medical screening Multidisciplinary teams Myocarditis Policies Pregnancy Public health Serology Vaccines Womens health |
| title | Screening policies for cytomegalovirus in pregnancy in the era of antivirals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T20%3A59%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20policies%20for%20cytomegalovirus%20in%20pregnancy%20in%20the%20era%20of%20antivirals&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Roberts,%20Sophie%20Louise&rft.aucorp=UCL%20cCMV%20MDT&rft.date=2022-08-13&rft.volume=400&rft.issue=10351&rft.spage=489&rft.epage=490&rft.pages=489-490&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(22)01299-5&rft_dat=%3Cproquest_cross%3E2701012810%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2701012810&rft_id=info:pmid/&rft_els_id=S0140673622012995&rfr_iscdi=true |